Amazon's $3.9B Purchase of 1Life's One Medical Faces Delay Due to FTC Investigation
Amazon's $3.9B Purchase of 1Life's One Medical Faces Delay Due to FTC Investigation
The Federal Trade Commission (FTC) is investigating the $3.9 billion transaction between $Amazon (AMZN.US)$ and $1Life Healthcare (ONEM.US)$.
这个联邦贸易委员会美国联邦贸易委员会(FTC)正在调查这笔39亿美元的交易$亚马逊 (AMZN.US)$和$1Life Healthcare (ONEM.US)$.
What Happened: According to a filing with the U.S. Securities and Exchange Commission, the FTC sent a notice to each company requesting "additional information and documentary materials" about the deal.
怎么了：根据提交给美国联邦调查局的一份文件美国证券交易委员会联邦贸易委员会向每家公司发出通知，要求提供有关这笔交易的“额外信息和文件材料”。
Amazon first announced a deal for One Medical, a primary care provider owned by 1Life, in July. The Seattle-based e-commerce giant reportedly outbid $CVS Health (CVS.US)$ in an auction process.
今年7月，亚马逊首次宣布与1Life旗下的初级保健提供商One Medical达成交易。据报道，这家总部位于西雅图的电商巨头出价高于$西维斯健康 (CVS.US)$在拍卖过程中。
Why It's Important: A federal probe like this one may delay the acquisition process.
为什么它很重要：像这样的联邦调查可能会推迟收购进程。
The request extends the waiting period imposed by the Hart-Scott-Rodino Act "until 30 days after One Medical and Amazon have substantially complied with the Second Request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC," the filing stated.
文件称，该请求将哈特-斯科特-罗迪诺法案规定的等待期延长至“One Medical和亚马逊基本上遵守第二项请求后30天，除非双方自愿延长或联邦贸易委员会更早终止该期限”。
The news is also a hiccup for Amazon CEO Andy Jassy, who took the helm from founder Jeff Bezos in July 2021. One of Jassy's goals is to bolster Amzon's healthcare offerings. The One Medical deal, Jassy's first major M&A move as CEO, would give Amazon ownership of some 180 clinics.
这一消息对亚马逊首席执行官来说也是一个小问题安迪·贾西，他从方正手中接过了方向盘Jeff·贝佐斯2021年7月。Jassy的目标之一是支持Amzon的医疗服务。One Medical的交易是贾西就任首席执行官后的第一次重大并购行动，它将使亚马逊拥有大约180家诊所。
Price Target: Amazon closed Friday at $127.51 per share — down 0.24%. Meanwhile, 1Life closed at $17.40 a share — up 0.35%.
目标价格：亚马逊周五收于每股127.51美元，下跌0.24%.与此同时，1Life收盘报每股17.40美元，上涨0.35%。